Study type

Study type

Non-interventional study

Scope of the study

Assessment of risk minimisation measure implementation or effectiveness
Non-interventional study

Non-interventional study design

Cohort
Study drug and medical condition

Anatomical Therapeutic Chemical (ATC) code

(B01AA) Vitamin K antagonists
Vitamin K antagonists
(B01AE07) dabigatran etexilate
dabigatran etexilate
(B01AF) Direct factor Xa inhibitors
Direct factor Xa inhibitors

Medical condition to be studied

Haemorrhage
Ischaemic stroke
Acute myocardial infarction
Glaucoma
Population studied

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

44000
Study design details

Main study objective

The objective is to assess whether the implementation of a study specific CDM and a general CDM, versus using a common protocol alone has an impact on the consistency of the study results of a pharmacoepidemiologic study in real-world data.

Outcomes

TBC, TBC

Data analysis plan

TBC